Back to Search
Start Over
Pomalidomide-based treatment in relapsed refractory mulitiple myeloma: Analysis of baseline characteristics and safety profile of patients who died in the European post approval safety study: PS1418
- Source :
- Gamberi, B, Abildgaard, N, Ramirez Payer, A, Kyriakou, C, Schmidt Hieber, M, Di Raimondo, F, Kueenburg, E, Di Micco, A, Rosettani, B, Atiba-Davies, M, Bacon, P & Plesner, T 2019, ' Pomalidomide-based treatment in relapsed refractory mulitiple myeloma: Analysis of baseline characteristics and safety profile of patients who died in the European post approval safety study: PS1418 ', HemaSphere, vol. 3, 652 . https://doi.org/10.1097/01.HS9.0000563948.69931.ef
- Publication Year :
- 2019
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- Gamberi, B, Abildgaard, N, Ramirez Payer, A, Kyriakou, C, Schmidt Hieber, M, Di Raimondo, F, Kueenburg, E, Di Micco, A, Rosettani, B, Atiba-Davies, M, Bacon, P & Plesner, T 2019, ' Pomalidomide-based treatment in relapsed refractory mulitiple myeloma: Analysis of baseline characteristics and safety profile of patients who died in the European post approval safety study: PS1418 ', HemaSphere, vol. 3, 652 . https://doi.org/10.1097/01.HS9.0000563948.69931.ef
- Accession number :
- edsair.doi.dedup.....85b052531b9aeb3f156c0d54dd6f3093